Shih-chao Hsu - Publications

Systemic Treatment Strategies for Recurrent Hepatocellular Carcinoma Following Liver Transplantation: A 20-y Retrospective Analysis With Clinical Insights.

Journal: Transplantation

Published: May 01, 2026

Immune Checkpoint Inhibitors for Recurrent Hepatocellular Carcinoma After Liver Transplantation: Safety Under an Immunosuppression-Preserving Strategy.

Journal: Annals of transplantation

Published: March 24, 2026

Early graft failure after adult living donor liver transplantation: A multicenter risk analysis and development of the early allograft failure in living donor liver transplantation (EAGLE-LDLT) model.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: July 19, 2025

Disrupting DDB2-DNA Interaction by Lapatinib Enhances Chemotherapy Sensitivity.

Journal: International journal of biological sciences

Published: April 21, 2025

Validation of a Pretransplant Risk Prediction Model for Early Allograft Dysfunction After Living-donor Liver Transplantation.

Journal: Transplantation

Published: January 30, 2025

Manipulating the Crosstalk between Cancer and Immunosuppressive Cells with Phototherapeutic Gold-Nanohut for Reprogramming Tumor Microenvironment.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 23, 2024

Adjuvant Sorafenib for Postoperative Patients with Hepatocellular Carcinoma and Macrovascular Invasion.

Journal: Current oncology (Toronto, Ont.)

Published: October 24, 2023

Biliary complications after adult-to-adult living-donor liver transplantation: An international multicenter study of 3633 cases.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: September 04, 2023

Modified Albumin-Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy.

Journal: Cancers

Published: September 17, 2022

Association of Increased Programmed Death Ligand 1 Expression and Regulatory T Cells Infiltration with Higher Hepatocellular Carcinoma Recurrence in Patients with Hepatitis B Virus Pre-S2 Mutant after Curative Surgical Resection.

Journal: Viruses

Published: April 02, 2022

Association of Low Serum Albumin Level with Higher Hepatocellular Carcinoma Recurrence in Patients with Hepatitis B Virus Pre-S2 Mutant after Curative Surgical Resection.

Journal: Journal of clinical medicine

Published: August 24, 2021

ABO-Incompatible Living Donor Liver Transplantation with Reduced Rituximab Dose: A Retrospective Analysis of 65 Patients - Can We Fast-Track Liver Transplant Surgery and Improve Long-Term Survival?

Journal: Annals of transplantation

Published: September 18, 2020